Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Treatment of unipolar psychotic depression: an open study of lithium addition in refractory psychotic depression.

Birkenhäger TK, van den Broek WW, Wijkstra J, Bruijn JA, van Os E, Boks M, Verkes RJ, Janzing JG, Nolen WA.

J Clin Psychopharmacol. 2009 Oct;29(5):513-5. doi: 10.1097/JCP.0b013e3181b6744e. No abstract available.

PMID:
19745662
2.
3.

Lithium in unipolar depression and the prevention of suicide.

Coppen A.

J Clin Psychiatry. 2000;61 Suppl 9:52-6. Review.

4.

Lithium augmentation for treatment-resistant depression in the elderly.

Lafferman J, Solomon K, Ruskin P.

J Geriatr Psychiatry Neurol. 1988 Jan;1(1):49-52.

PMID:
3150926
5.

Divalproex sodium in the treatment of refractory affective disorders.

Schaff MR, Fawcett J, Zajecka JM.

J Clin Psychiatry. 1993 Oct;54(10):380-4.

PMID:
8262880
6.

The clinical profile of psychotic depression.

Samuel M, Varghese M.

Aust N Z J Psychiatry. 2003 Feb;37(1):111. No abstract available.

PMID:
12534668
7.

Lithium versus placebo in acute depression: a clinical trial.

Khan MC, Wickham EA, Reed JV.

Int Clin Psychopharmacol. 1987 Jan;2(1):47-54.

PMID:
3117877
8.

The effectiveness of lithium prophylaxis in bipolar and unipolar depressions and schizo-affective disorders.

Bouman TK, Niemantsverdriet-van Kampen JG, Ormel J, Slooff CJ.

J Affect Disord. 1986 Nov-Dec;11(3):275-80.

PMID:
2951414
9.

Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder.

Winkler D, Willeit M, Wolf R, Stamenkovic M, Tauscher J, Pjrek E, Konstantinidis A, Schindler S, Barnas C, Kasper S.

Eur Neuropsychopharmacol. 2003 Mar;13(2):129-34.

PMID:
12650958
10.

Duration of lithium treatment and brain lithium concentration in patients with unipolar and schizoaffective disorder--a study with magnetic resonance spectroscopy.

Riedl U, Barocka A, Kolem H, Demling J, Kaschka WP, Schelp R, Stemmler M, Ebert D.

Biol Psychiatry. 1997 Apr 15;41(8):844-50.

PMID:
9099410
11.

Clozapine in the treatment of psychotic refractory depression.

Dassa D, Kaladjian A, Azorin JM, Giudicelli S.

Br J Psychiatry. 1993 Dec;163:822-4.

PMID:
8306130
12.

Adverse events and tolerability of the combination of fluoxetine/lithium compared with fluoxetine.

Bauer M, Linden M, Schaaf B, Weber HJ.

J Clin Psychopharmacol. 1996 Apr;16(2):130-4.

PMID:
8690828
13.

[Investigation of episode-characteristics of unipolar psychotic depression].

Kühner C.

Nervenarzt. 2000 May;71(5):393-400. German.

PMID:
10846715
14.

Relationship between patient variables and lithium dosage requirements.

Lesar TS, Tollefson G, Koch M.

J Clin Psychiatry. 1985 Apr;46(4):133-6.

PMID:
3980451
15.

The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT.

Flint AJ, Rifat SL.

Int J Geriatr Psychiatry. 1998 Jan;13(1):23-8.

PMID:
9489577
16.

After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression.

Nierenberg AA, Price LH, Charney DS, Heninger GR.

J Affect Disord. 1990 Mar;18(3):167-75.

PMID:
2139061
17.

Refractory depression: the addition of lithium to fluoxetine or desipramine.

Ontiveros A, Fontaine R, Elie R.

Acta Psychiatr Scand. 1991 Mar;83(3):188-92.

PMID:
1903237
18.

Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients.

Schumann C, Lenz G, Berghöfer A, Müller-Oerlinghausen B.

Psychiatry Res. 1999 Dec 27;89(3):247-57.

PMID:
10708271
19.

Lithium potentiation of antidepressant treatment.

Louie AK, Meltzer HY.

J Clin Psychopharmacol. 1984 Dec;4(6):316-21.

PMID:
6511998
20.

Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.

Meco G, Bernardi S.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):311-3.

PMID:
16919377

Supplemental Content

Support Center